Relative activity and specificity of promoters from prostate-expressed genes

Prostate

Volumn 35, Issue 1, 1998, Pages 18-26

  Brookes, D E ^a   Zandvliet, D ^a,b   Watt, F ^a   Russell, P J ^b   Molloy, P L ^a  

^a CSIRO   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Androgen; Probasin; Prostate specific antigen; Relaxin

Indexed keywords

ANDROGEN RECEPTOR; CHLORAMPHENICOL ACETYLTRANSFERASE; PROBASIN; PROSTATE SPECIFIC ANTIGEN; RELAXIN; SERINE ACETYLTRANSFERASE;

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CELL CULTURE; CELL TYPE; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE; PROSTATE CARCINOMA; ROUS SARCOMA ONCOVIRUS;

ACETYLTRANSFERASES; ANDROGEN-BINDING PROTEIN; BREAST NEOPLASMS; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; GENE EXPRESSION; HUMANS; LIVER NEOPLASMS; MALE; PROMOTER REGIONS (GENETICS); PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECOMBINANT FUSION PROTEINS; RELAXIN; SERINE O-ACETYLTRANSFERASE; TRANSFECTION; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0031920589     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980401)35:1<18::AID-PROS3>3.0.CO;2-D     Document Type: Article

References (39)

1. Cleutjens KBJM, van Eekelen CCEM, van der Korput HAGM, Brinkmann AO, Trapman J: Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J Biol Chem 1996;271:6379-6388.
2. Riegman PHJ, Vliestra RJ, van der Korput JAGM, Brinkmann AO, Trapman J: The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol Endocrinol 1991;5:1921-1930.
3. Murtha P, Tindall DJ, Young CYF: Androgen induction of a human prostate-specific kallikrein, hKLK2-characterization of an androgen response element in the 5' promoter region of the gene. Biochemistry 1993;32:6459-6464.
4. Claessens F, Rushmere NK, Davies P, Celis L, Peeters B, Rombauts WA: Sequence-specific binding of androgen-receptor complexes to prostatic binding protein genes. Mol Cell Endocrinol 1990;74:203-212.
5. Rushmere NK, Parker MG, Davies P: Androgen-receptor binding regions of an androgen responsive gene. Mol Cell Endocrinol 1987;51:259-265.
6. Kasper S, Rennie PS, Bruchovsky N, Sheppard PC, Cheng H, Lin L, Shiu RPC, Snoek R, Matusik RJ: Cooperative binding of androgen receptors to two DNA sequences is required for androgen induction of the probasin gene. J Biol Chem 1994;269:31763-31769.
7. Rennie PS, Bruchovsky N, Leco KJ, Sheppard PC, McQueen SA, Cheng H, Snoek R, Hamel A, Bock ME, MacDonald BS, Nickel BE, Chang C, Liao S, Cattini PA, Matusik RJ: Characterization of two as-acting DNA elements involved in the regulation of the probasin gene. Mol Endocrinol 1993;7:23-36.
8. Virkkunen P, Hedberg P, Palvimo JJ, Birr E, Porvari K, Ruokonen M, Taavitsainen P, Jänne OA, Vihko P: Structural comparison of human and rat prostate-specific acid phosphatase genes and their promoters: Identification of putative androgen response elements. Biochem Biophys Res Commun 1994;202:49-57.
9. Ho KC, Marschke KB, Tan JA, Power SGA, Wilson EM, French FS: A complex response element in intron-1 of the androgen-regulated 20-kDa protein gene displays cell Type-Dependent androgen receptor specificity. J Biol Chem 1993;268:27226-27235.
10. Celis L, Claessens F, Peeters B, Heyns W, Verhoeven G, Rombauts W: Proteins interacting with an androgen-responsive unit in the C3(1) gene intron. Mol Cell Endocrinol 1993;94:165-172.
11. Zhang Y-L, Parker MG, Bakker O: Tissue-specific differences in the binding of nuclear proteins to a CCAAT motif in the promoter of the androgen-regulated C3 gene. Mol Endocrinol 1990; 4:1219-1225.
12. Greenberg NM, Demayo FJ, Sheppard PC, Barrios R, Lebovitz R, Finegold M, Angelopoulou R, Dodd JG, Duckworth ML, Rosen JM, Matusik RJ: The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol 1994;8:230-239.
13. Greenberg NM, Demayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM: Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995;92:3439-3443.
14. Allison J, Zhang Y-L, Parker MG: Tissue-specific and hormonal regulation of the gene for rat prostatic steroid-binding protein in transgenic mice. Mol Cell Biol 1989;9:2254-2257.
15. Maroulakou IG, Anver M, Garrett L, Green JE: Prostate and mammary adenocarcinoma in transgenic mice carrying a rat c3(1) simian virus 40 large tumor antigen fusion gene. Proc Natl Acad Sci USA 1994;91:11236-11240.
16. Schaffner DL, Barrios R, Shaker MR, Rajagopalan S, Huang SL, Tindall DJ, Young CYF, Overbeek PA, Lebovitz RM, Lieberman MW: Transgenic mice carrying a PSArasT24 hybrid gene develop salivary gland and gastrointestinal tract neoplasms. Lab Invest 1995;72:283-290.
17. Hansell DJ, Bryant-Greenwood GD, Greenwood FC: Expression of the human relaxin H1 gene in the decidua, trophoblast and prostate. J Clin Endocrinol Metab 1991;72:899-904.
18. Ivell R, Hunt N, Khan-Dawood F, Dawood MY: Expression of the human relaxin gene in the corpus luteum of the menstrual cycle and in the prostate. Mol Cell Endocrinol 1989;66:251-255.
19. Winslow JW, Shih A, Bourell JH, Weiss G, Reed B, Stults JT, Goldsmith LT: Human seminal relaxin is a product of the same gene as human luteal relaxin. Endocrinology 1992;130:2660-2668.
20. Weiss G, O'Byrne EM: Relaxin: A product of the corpus luteum of pregnancy. Science 1976;194:948-949.
21. Sivaprasad AV, Kuczek ES, Bawden CS, Rogers GE: Coexpression of the cysE and cysM genes of Salmonella typhimurium in mammalian cells: A step toward establishing cysteine biosynthesis in sheep by transgenesis. Transgenic Res 1992;1:79-92.
22. Gunnersen JM, Roche PJ, Tregear GW, Crawford RJ: Characterization of human relaxin gene regulation in the relaxinexpressing human prostate adenocarcinoma cell line LNCaP.FGC. J Mol Endocrinol 1995;15:153-166.
23. Hudson P, John M, Crawford R, Haralambidis J, Scanlon D, Gorman J, Tregear G, Shine J, Niall H: Relaxin gene expression in human ovaries and the predicted structure of a human preprorelaxin by analysis of cDNA clones. EMBO J 1984;3:2333-2339.
24. Tilley WD, Marcelli M, Wilson JD, McPhaul MJ: Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci USA 1989;86:327-331.
25. Lathe R, Vilotte JL, Clark AJ: Plasmid and bacteriophage vectors for excision of intact inserts. Gene 1987;57:193-201.
26. Gorman CM, Merlino GT, Willingham MC, Pastan I, Howard BH: The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DMA-mediated transfection. Proc Natl Acad Sci USA 1982;79: 6777-6781.
27. Russell PJ, Wass J, Lukeis R, Garson OM, Jelbart M, Wills EJ, Philips J, Brown J, Carrington N, Vincent PC, Raghavan D: Characterization of cell lines derived from a multiply aneuploid human bladder transitional-cell carcinoma, UCRU-BL-13. Int J Cancer 1989;44:276-285.
28. Thalmann GN, Sikes RA, Chang S-M, Johnston DA, von Eschenbach AC, Chung LWK: Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer. J Natl Cancer Inst 1996;88:794-801.
29. Sleigh MJ: A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells. Anal Biochem 1986;156:251-256.
30. Schuur ER, Henderson GA, Kmetec LA, Miller JD, Lamparski HG, Henderson DR: Prostate-specific antigen expression is regulated by an upstream enhancer. J Biol Chem 1996;271:7043-7051.
31. Veldscholte JCR, Kuiper GG, Jenster G, Berrevoets C, Claessen E, vanRooij HC, Trapman J, Brinkmann AO: A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun 1990;173:534-540.
32. Demura T, Kuzumaki N, Oda A, Fujita H, Ishibashi T, Koyanagi T: Establishment and characterization of monoclonal antibody against androgen receptor. J Steroid Biochem 1989;33:845-851.
33. Tilley WD, Marcelli M, McPhaul MJ: Expression of the human androgen receptor gene utilizes a common promoter in diverse human tissues and cell lines. J Biol Chem 1990;265:13776-13781.
34. Pang S, Taneja S, Dardashti K, Cohan P, Kaboo R, Sokoloff M, Tso C-L, Dekernion JB, Belldegrun AS: Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer. Hum Gene Ther 1995;6:1417-1426.
35. Diamandis EP, Yu H, Sutherland DJA: Detection of prostate-specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 1994;32:301-310.
36. Adler AJ, Danielsen M, Robins DM: Androgen-specific gene activation via a consensus glucocorticoid response element is determined by interaction with nonreceptor factors. Proc Natl Acad Sci USA 1992;89:11660-11663.
37. Kupfer SR, Marschke KB, Wilson EM, French FS: Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors. J Biol Chem 1993;268:17519-17527.
38. Yeh SY, Chang CS: Cloning and characterization of a specific coactivator, ARA(70), for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 1996;93:5517-5521.
39. Eastham JA, Chen SH, Sehgal I, Yang G, Timme TL, Hall SJ, Woo SLC, Thompson TC: Prostate cancer gene therapy: Herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. Hum Gene Ther 1996;7:515-523.